E-DRUG: WIPO and TRIPS?
Sometime in the fairly recent past (1-2 years ago) I dimly recall reading a
paper that was critical of the advice that WIPO (World Intellectual Property
Organization) was offering developing countries regarding how they could
make their patent laws TRIPS complaint while still preserving maximum
flexibility. Despite much searching I cannot now find this article, if
indeed it ever existed. Does anyone on this list know of such a piece?
Joel Lexchin MD
121 Walmer Rd.
Canada M5R2 2X8
e mail: email@example.com
[WIPO indeed has a contract from WTO to assist developing countries becoming
TRIPS compliant. However, my experience is that the do not pay much
attention to flexibilities, but more to strengthening IPR legislation.
Anyway, does anyone know of a published source? WB]
To send a message to E-Drug, write to: firstname.lastname@example.org
To subscribe or unsubscribe, write to: email@example.com
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: firstname.lastname@example.org
Information and archives: http://www.essentialdrugs.org/edrug